Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology
Published in: European Archives of Oto-Rhino-Laryngology 10/2016

01-10-2016 | Otology

Acetazolamide in vestibular migraine prophylaxis: a retrospective study

Authors: Neşe Çelebisoy, Figen Gökçay, Ceyda Karahan, Cem Bilgen, Tayfun Kirazlı, Hale Karapolat, Timur Köse

Published in: European Archives of Oto-Rhino-Laryngology | Issue 10/2016

Login to get access

Abstract

The aim of this study is to check the efficacy of acetazolamide in the prophylaxis of vestibular migraine (VM). Treatment options in VM are mainly based on migraine guidelines. We tried to assess the efficacy of acetazolamide in these patients depending on clinical similarities with episodic ataxia type 2 and familial hemiplegic migraine responding to the drug. This is a retrospective cohort study. Among 50 patients with VM and prescribed acetazolamide 500 mg/day, 39 patients were studied as five had been lost on follow-up and six had stopped taking the drug due to side effects. Vertigo and headache frequency determined by number of attacks per month, and the severity determined by visual analog scales measured in centimeters from 0 to 10 were collected from the records. Initial reported figures for frequency and severity were compared with the results gathered after 3 months of treatment. The results were compared. Acetazolamide was effective in reducing both the frequency and severity of vertigo and headache attacks and this effect was more prominent for vertigo frequency and severity.
Literature
1.
2.
3.
Cass SP, Furman JM, Ankerstjerne K, Balaban C, Yetişer S, Aydogan B (1997) Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 106:182–189CrossRefPubMed
4.
5.
Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T (2001) The interrelations of migraine, vertigo and migrainous vertigo. Neurology 56:436–441CrossRefPubMed
6.
Reploeg MD, Goebel JA (2002) Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 23:364–371CrossRefPubMed
7.
Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, Bisdorff A, Versino M, Evers S, Newman-Toker D (2012) Vestibular migraine: diagnostic criteria. J Vest Res 22:167–172
8.
International Headache Society Classification Subcommittee (2013) The International Classification of Headache disorders, 3rd edition (beta version). Cephalalgia 33:629–808CrossRef
9.
Neuhauser H, Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, Lempert T (2006) Migrainous vertigo: prevalence and impact on quality of life. Neurology 67:1028–1033CrossRefPubMed
10.
Neff BA, Staab JP, Eggers SD, Carlson ML, Schmitt WR, Van Abel KM, Worthington DK, Beatty CW, Driscoll CL, Shepard NT (2012) Auditory and vestibular symptoms and chronic subjective dizziness in patients with Meniere’s disease, vestibular migraine and Meniere’s disease with concomitant vestibular migraine. Otol Neurotol 33:1235–1244CrossRefPubMed
11.
Radtke A, von Brevern M, Neuhauser H, Hottenrott T, Lempert T (2012) Vestibular migraine: long term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology 79:1607–1614CrossRefPubMed
12.
Celebisoy N, Gökçay F, Sirin H, Bıçak N (2008) Migrainous vertigo: clinical, oculographic and posturographic findings. Cephalalgia 28:72–77PubMed
13.
Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543–552CrossRefPubMed
14.
Von Brevern M, Ta N, Shankar A, Wieste A, Siegel A, Radtke A, Sander T, Escayg A (2006) Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache 46(1136–1):141
15.
Kim JS, Yue Q, Jen JC, Nelson SF, Baloh RW (1998) Familial migraine with vertigo: no mutations found in CACNA1A. Am J Med Gen 79:148–151CrossRef
16.
Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A (2014) Flunarizine in the prophylaxis of migrainous vertigo. Eur Arch Otorhinolaryngol 271:2931–2936CrossRefPubMed
17.
Bikhazi P, Jackson C, Ruckenstein MJ (1997) Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 18:350–354PubMed
18.
Maione A (2006) Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 116:1782–1786CrossRefPubMed
19.
Baier B, Winkenwerder E, Dieterich M (2009) “Vestibular migraine”: effects of prophylactic therapy with various drugs. A retrospective study. J Neurol 256:436–442CrossRefPubMed
20.
Bisdorff AR (2004) Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb 2:103–108PubMed
21.
Gode S, Celebisoy N, Kirazli T, Akyuz A, Bilgen C, Karapolat H, Sirin H, Gokcay F (2010) Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache 50:77–84CrossRefPubMed
22.
Taghdiri F, Togha M, Jahromi SR, Refaeian F (2014) Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Springerplus 3:231–235CrossRefPubMedPubMedCentral
23.
Kohshi K, Konda N, Kinoshita Y, Tsuru E, Yokota A (1994) In situ arterial and brain tissue PCO2 responses to acetazolamide in cats. J Appl Physiol 76:2199–2203PubMed
24.
Aggarwal M, Kondeti B, McKenna R (2013) Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review. Expert Opin Ther Pat 23:717–724CrossRefPubMed
25.
De Simone R, Marano E, Di Stasio E, Bonuso S, Fiorillo C, Bonavita V (2005) Acetazolamide efficacy and tolerability in migraine with aura: a pilot study. Headache 45:385–386CrossRefPubMed
26.
Robbins MS, Lipton RB, Laureta EC, Grosberg BM (2009) CACNA1A nonsense mutation is associated with basilar-type migraine and episodic ataxia type 2. Headache 49:1042–1046CrossRefPubMed
27.
Tricarico D, Barbieri MG, Conte Camerino D (2000) Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann Neurol 48:304–312CrossRefPubMed
28.
Omata T, Takanashi J, Wada T, Arai H, Tanabe Y (2011) Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine. Brain Dev 33:332–334CrossRefPubMed
29.
Shirai T, Meyer JS, Akiyama H, Mortel KF, Wills PM (1996) Acetazolamide testing of cerebral vasodilator capacity provokes ‘vascular’ but not tension headaches. Headache 36:589–594CrossRefPubMed
30.
Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS (2009) EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol 16:968–981CrossRefPubMed
31.
Loder E, Burch R, Rizzoli P (2012) The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache 52:930–945CrossRefPubMed
32.
Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013) Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults (review). Cochrane Database Syst Rev 6:1–58
33.
Baloh RW, Foster CA, Yue Q, Nelson SF (1996) Familial migraine with vertigo and essential tremor. Neurology 46:458–460CrossRefPubMed
Metadata
Title
Acetazolamide in vestibular migraine prophylaxis: a retrospective study
Authors
Neşe Çelebisoy
Figen Gökçay
Ceyda Karahan
Cem Bilgen
Tayfun Kirazlı
Hale Karapolat
Timur Köse
Publication date
01-10-2016
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 10/2016
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-015-3874-4

Other articles of this Issue 10/2016

European Archives of Oto-Rhino-Laryngology 10/2016 Go to the issue

Erratum

Erratum to: Woodworkers and the inflammatory effects of softwood/hardwood dust: evidence from nasal cytology

Miscellaneous

Cross-cultural validation of a taste test with paper strips

Otology

Lateralization of horizontal semicircular canal canalolithiasis and cupulopathy using bow and lean test and head-roll test

Head and Neck

Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma

Rhinology

Reconstruction of the denuded nasoseptal flap donor site with a free fascia lata graft: technical note

Letter to the Editor

A proposal for a level for parapharyngeal extension of parotid gland